Intrinsic Value of S&P & Nasdaq Contact Us

PRF Technologies Ltd. PRFX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
21/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Over the last 12 months, insiders have made 7 transactions in PRFX stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

PRFX Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-18 Aviel Sigal Chief Operating Officer Unknown 3,000 $15.75 $47.25K
2026-03-18 Shavit Asaf Director Unknown 3,000 $5.55 $16.65K
2026-03-18 Cohen-arazi Efraim Interim CEO Unknown 3,000 $15.75 $47.25K
2026-03-18 Broder Eyal Chief Financial Officer Unknown 2,000 $15.75 $31.5K
2026-03-18 Geller Ehud Exec Chairman of the Board Unknown 150 $706.80 $106.02K
2026-03-18 Lawlor Augustine Director Unknown 183 $30.00 $5.49K
2026-03-18 Baron Ellen S Director Unknown 183 $30.00 $5.49K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message